Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Dolinger

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Pediatric Gastroenterology and Nutrition|January 31, 2025
Ustekinumab is safe and effective in pediatric patients with Crohn's diseaseElana B Mitchel, Michael T Dolinger, Brad Constant, et al.
Inflammatory Bowel Diseases|May 23, 2024
Challenges in IBD Research 2024: Novel TechnologiesShalini Prasad, Raymond K Cross, Mary Beth Monroe, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2025
Expert Position Statement: Defining the Role of Intestinal Ultrasound in Assessing Constipation and Faecal LoadingRyan M Mathias, Thomas M Goodsall, Claire E Parker, et al.
Alimentary Pharmacology & Therapeutics|August 14, 2025
Editorial: Intestinal Ultrasound for the Assessment of Constipation-Out of the Shadows? Authors' ReplyRyan M Mathias, Thomas M Goodsall, Claire E Parker, et al.
Gastroenterology|March 27, 2025
Active Inflammatory Bowel Disease on Intestinal Ultrasound During Pregnancy Is Associated With an Increased Risk of Adverse Pregnancy and Neonatal Outcomes Independent of Clinical and Biochemical Disease ActivityRalley E Prentice, Emma K Flanagan, Emily K Wright, et al.
Journal of Crohn'S & Colitis|November 28, 2024
Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multicenter StudyAnat Yerushalmy-Feler, Elizabeth A Spencer, Michael T Dolinger, et al.
Alimentary Pharmacology & Therapeutics|February 8, 2025
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective StudyShlomi Cohen, Elizabeth A Spencer, Michael T Dolinger, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Pediatric Gastroenterology and Nutrition|January 31, 2025
Ustekinumab is safe and effective in pediatric patients with Crohn's diseaseElana B Mitchel, Michael T Dolinger, Brad Constant, et al.
Inflammatory Bowel Diseases|May 23, 2024
Challenges in IBD Research 2024: Novel TechnologiesShalini Prasad, Raymond K Cross, Mary Beth Monroe, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2025
Expert Position Statement: Defining the Role of Intestinal Ultrasound in Assessing Constipation and Faecal LoadingRyan M Mathias, Thomas M Goodsall, Claire E Parker, et al.
Alimentary Pharmacology & Therapeutics|August 14, 2025
Editorial: Intestinal Ultrasound for the Assessment of Constipation-Out of the Shadows? Authors' ReplyRyan M Mathias, Thomas M Goodsall, Claire E Parker, et al.
Gastroenterology|March 27, 2025
Active Inflammatory Bowel Disease on Intestinal Ultrasound During Pregnancy Is Associated With an Increased Risk of Adverse Pregnancy and Neonatal Outcomes Independent of Clinical and Biochemical Disease ActivityRalley E Prentice, Emma K Flanagan, Emily K Wright, et al.
Journal of Crohn'S & Colitis|November 28, 2024
Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multicenter StudyAnat Yerushalmy-Feler, Elizabeth A Spencer, Michael T Dolinger, et al.
Alimentary Pharmacology & Therapeutics|February 8, 2025
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective StudyShlomi Cohen, Elizabeth A Spencer, Michael T Dolinger, et al.
Pageof 3